Table 1.
Association of SIRT5 expression with clinicopathological characteristics of ovarian cancer tissue microarrays.
| Clinicopathological characteristics | Total number | SIRT5 negative or weak expression | SIRT5 positive expression | P value |
|---|---|---|---|---|
| Age | 0.0786 | |||
| <60 | 73 | 47 (64.38%) | 7 (35.62%) | |
| ≥60 | 17 | 7 (41.18%) | 10 (58.82%) | |
| Histology | 0.085 | |||
| Serous carcinoma | 72 | 40 (55.56%) | 32 (44.44%) | |
| Mucinous adenocarcinoma+others | 18 | 14 (77.78%) | 4 (22.22%) | |
| Differentiation | 0.0179 | |||
| High grade | 65 | 34 (52.31%) | 31 (47.69%) | |
| Low grade | 25 | 20 (80.00%) | 5 (20.00%) | |
| Figo stage | <0.0001 | |||
| I | 47 | 44 (93.62%) | 3 (6.38%) | |
| II-IV | 43 | 10 (23.26%) | 33 (76.74%) | |
| Lymph node metastasis | 0.0019 | |||
| Negative | 68 | 47 (69.12%) | 21 (30.88%) | |
| Positive | 22 | 7 (31.82%) | 15 (68.18%) |
The bold fonts represent the significant values.